Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

T-knife and Catalent Sign Technology Transfer and Manufacturing Agreement for Autologous T-Cell Receptor-Based Cell Therapy


We are convinced that Catalent is the right partner for T-knife to ensure premier manufacturing of our pipeline programs, covering all stages from clinical trials to market

T-knife GmbH, a next-generation adoptive T-cell company using its proprietary humanized T-cell receptor (HuTCR) mouse platform to treat solid tumors, and Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced they have signed an agreement to provide technology transfer and CGMP clinical manufacturing of T-knife’s T1367 T-cell receptor (TCR) program.

T1367 is an autologous T-cell receptor-based cell therapy derived from T-knife’s proprietary humanized T-cell receptor (HuTCR) mouse platform and specifically targets MAGE-A1 positive tumors in cancer patients. The therapy is expected to be manufactured for clinical trials in both the European Union and the United States.

Under the terms of the agreement, Catalent will undertake transfer of T-knife’s platform process for T-cell receptor-based cell therapy at its site in Gosselies, Belgium, with the goal of manufacturing clinical batches for European trials in 2021. T-knife will also prepare for the transfer of the TCR manufacturing platform to Catalent’s Houston, Texas, facility with a view to initiating clinical trials in North America in the future.

“The product candidates based on our proprietary HuTCR platform require sophisticated, state-of-the-art manufacturing capabilities and deep cell and gene therapy know-how,” said Michael Buchholz, Director Manufacturing of T-knife. “We are convinced that Catalent is the right partner for T-knife to ensure premier manufacturing of our pipeline programs, covering all stages from clinical trials to market.”

“Catalent is well-suited to support T-knife with focused technology transfer and process industrialization in both Gosselies and Houston,” commented Manja Boerman, Ph.D., President, Cell & Gene Therapy, Catalent. “Emerging and innovative treatments like T1367 are moving rapidly to the clinic. Catalent is committed to continual investment and expansion to support our clients as they continue on the journey to commercialization.”

Catalent’s 2,400 square-metre (25,830 square-foot) facility in Gosselies, Belgium, provides clinical through commercial-scale cell therapy manufacturing, for both autologous and allogeneic cell therapy treatments. The facility accommodates four process development laboratories, nine flexible manufacturing clean rooms for cGMP manufacturing, as well as fill and finish services and quality control laboratories. An additional large-scale commercial manufacturing plant is currently under construction at the site and expected to be fully commissioned in 2021. The company also has a clinical manufacturing site in Houston, which is under qualification and expected to be fully commissioned in 2020.

About T-knife

T-knife is a next-generation adoptive T-cell company utilizing its proprietary humanized T-cell receptor (HuTCR) mouse platform technology to treat solid tumors. It was founded as a spin-off from Max-Delbruck Center for Molecular Medicine together with Charité University Hospital in Berlin in 2018.

T-knife´s mission is to use its unique technology to bring highly effective and safe T-cell receptor-based therapeutics to market. Based on the unparalleled T-cell immunology expertise of its founders and the unique and proprietary HuTCR platform, the Company develops fully human TCRs which are expected to set new technology standards and to provide superior safety and efficacy. The Company has demonstrated pre-clinical proof-of-concept and its lead TCR has entered clinical development. In addition, T-knife has validated the platform for over 90 undisclosed cancer targets, with several follow-on drug candidates being already in preclinical development. The Company expects to bring three additional TCRs into the clinic by 2022. T-knife is executing a two-pronged corporate growth strategy: developing an internal pipeline of best-in-class therapeutics and in parallel, establishing external partnerships by out-licensing already patented TCRs and/or providing the Company’s HuTCR mouse for unbiased discovery of new epitopes. T-knife is backed by top tier investors Versant Ventures, RA Capital, Andera Partners, and Boehringer Ingelheim Venture Fund.

About Catalent Cell & Gene Therapy

With deep experience in viral vector scale-up and production, Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) and lentiviral vectors, and CAR-T immunotherapies. When it acquired MaSTherCell, Catalent added expertise in autologous and allogeneic cell therapy development and manufacturing to position it as a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. Catalent has a global cell and gene therapy network of dedicated, large-scale clinical and commercial manufacturing facilities, and fill-finish and packaging capabilities located in both the U.S. and Europe. An experienced partner, Catalent Cell & Gene Therapy has worked with industry leaders across 70+ clinical and commercial programs

About Catalent

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs approximately 14,000 people including around 2,400 scientists and technicians, at more than 45 facilities, and in fiscal year 2020 generated over $3 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Share article on social media or email:

Compliancy Group Officially Provides Documentation and Training in Spanish


HIPAA Spanish

“Our clients were asking for Spanish resources for their employees. They asked, so we developed them. We strive to provide excellent customer service to our clients and are happy to provide them with the tools they need to be successful”

Compliancy Group understands that many organizations require HIPAA in Spanish for their Spanish-speaking employees. An important part of HIPAA compliance is the ability of staff members to understand their obligations to comply with the regulations. This is why it is important for all staff members to be able to read, understand, and legally attest to your organization’s policies and procedures, as well as undergo training that they can understand.

“Our clients were asking for Spanish resources for their employees. They asked, so we developed them. We strive to provide excellent customer service to our clients and are happy to provide them with the tools they need to be successful,” Marc Haskelson, CEO and President, Compliancy Group.

Compliancy Group has all of the documentation necessary for your organization to implement an effective compliance program available in Spanish. In addition, to ensure that your organization instills a culture of compliance, all of our training material is also available in Spanish.

HIPAA Resources:

HIPAA Compliance Manual

HIPAA Training

HIPAA Risk Assessment Software

About Compliancy Group:

Compliance should be simple. That’s why Compliancy Group is the only compliance software with expert Compliance Coaches holding your hand to simplify compliance. Listed on Inc. 2020 Best Places to Work and 2020 Inc. 5000 list of the fastest-growing private companies in America, you can be confident that when you choose to work with us, you will receive the best possible customer service. Having dedicated employees that care about their work means that they care about your success. Compliancy Group gives you peace of mind in your compliance plan reducing risk, increasing patient loyalty, and profitability of your organization.

Visit http://www.compliancy-group.com or call 855.854.4722 to learn how simple compliance can be.

Share article on social media or email:

Highmark, AstraZeneca Enter Outcomes-Based Agreement for Severe Asthma Medication Fasenra


“Highmark is committed to ensuring our members have access to the most clinically effective, cost-efficient medications possible.” – Sarah Marchè, SVP, pharmacy services, Highmark

Highmark announced that it has entered an outcomes-based agreement with AstraZeneca for Fasenra, an add-on prescription maintenance treatment for patients age 12 or older with severe asthma. Approximately 500 Highmark members utilize the healthcare professional administered formulation of Fasenra. This agreement monitors commercial and Medicare members.

Through outcomes-based agreements, drug companies are accountable for the clinical effectiveness of medications. As part of the agreement, Highmark is measuring members that stay on treatment signaling the treatment is working and the member’s health is improving.

“Highmark is committed to ensuring that our members have access to the most clinically effective, cost-efficient medications possible,” says Sarah Marchè, senior VP of pharmacy services for Highmark. “Outcomes-based agreements are an important component of realizing that goal, and AstraZeneca is a proven partner in this space.”

Previously, Highmark and AstraZeneca reached an outcomes-based agreement for the asthma and COPD medication SYMBICORT—one of the first outcomes-based agreements in the U.S. for the treatment of those chronic respiratory conditions. In 2019, Highmark announced that its contract with AstraZeneca for SYMBICORT demonstrated positive results in improving health outcomes, including through the majority of patients on the medication experiencing a stabilization or improvement of their symptoms.

More than 25 million Americans have been diagnosed with asthma, according to the Asthma and Allergy Foundation of America (AAFA). Each year, this chronic respiratory disease accounts for more than $50 billion in direct medical costs, and more than $3 billion in costs related to missed work and school days, per the AAFA.

This value-based contract with AstraZeneca for Fasenra continues Highmark’s streak of designing and implementing outcomes-based agreements for pharmaceutical and biological products that focus on improved health outcomes for members and ensuring the medications that they are using are working for them. Highmark previously entered into value-based contracts for the treatment of several other chronic, high-cost health conditions, including diabetes, autoimmune diseases, asthma and COPD.

About Highmark Inc.

One of America’s leading health insurance organizations and an independent licensee of the Blue Cross Blue Shield Association, Highmark Inc. (the Health Plan) and its affiliated health plans (collectively, the Health Plans) work passionately to deliver high-quality, accessible, understandable, and affordable experiences, outcomes, and solutions to customers. As the fourth-largest overall Blue Cross Blue Shield-affiliated organization, Highmark Inc. and its Blue-branded affiliates proudly cover the insurance needs of more than 5.6 million members in Pennsylvania, Delaware, and West Virginia. Its diversified businesses serve group customer and individual needs across the United States through dental insurance and other related businesses. For more information, visit http://www.highmark.com.

Share article on social media or email:

Baltimore Based Chiropractic and Physical Therapy Group Announces New Location


Mid-Atlantic Spinal Rehab CEO, Dr. Marc Gulitz, DC

Annapolis will be a fantastic location for us. We’re looking forward to being able to host an opening for our team and partners at an appropriate and safe future date. We’re always looking to expand our reach and are currently working on additional sites around the State of Maryland.

Mid-Atlantic Spinal Rehab & Chiropractic, a leading Chiropractic and Physical Therapy practice, today announced a new office location in the Annapolis area of Anne Arundel County. The new location, 2563 Forest Dr # 201, Annapolis, MD 21401, will be the company’s ninth location around Maryland, and will become home to a growing team of healthcare professionals.

According to CEO, Dr. Marc Gulitz, the expansion has been planned for some time. “Our vision has always been to serve the entire Baltimore Metro area, and then expand throughout the State and Region. We are excited about serving the needs of the citizens of Annapolis and Anne Arundel County, along with our referring Doctors and partners. We’re also committed to expanding our team and creating healthcare jobs throughout Maryland.”

Mid-Atlantic Spinal Rehab specializes in the care of acute injuries caused by automobile or work related accidents. Adding a new location is a strategic move that will allow them to have a physical presence in the City of Annapolis, expanding their patient care and reach to tens of thousands more Maryland residents.

“Given the number of residents, and referring partners in the City of Annapolis, and the surrounding communities,” says Dr. Gulitz, “we expect this new location to quickly grow in patient visits, and staff. Within six months we believe Annapolis will be seeing a similar volume to our eight other locations.”

About Mid-Atlantic Spinal Rehab & Chiropractic

Mid-Atlantic Spinal Rehab & Chiropractic specializes in the rehabilitation of acute musculoskeletal injuries, such as those commonly experienced in auto accidents and work related injuries. Our healthcare providers work alongside primary care physicians, pain management physicians, physical therapists, orthopedists, and neurologists to manage care, and provide positive outcomes for patients. Founded in 2012, Mid-Atlantic Spinal Rehab & Chiropractic is one of the fastest growing practices in the Region. For more information visit the website at http://www.midatlanticspinalrehab.com

About Growth Solutions Team

The Growth Solutions Team is a leading provider of Business Consulting, Sales & Customer Service Training, and Small Business Advisory services. Our team assists companies with revenue generation, profit maximization, business processes, Strategic HR, and business development. Our programs are designed to meet you where you are, and to generate lasting results for your company. For more information visit the website at http://www.growthsolutionsteam.com

Share article on social media or email:

Better Noise Films and the Amy Winehouse Foundation team up with Global Recovery Initiatives Foundation To Save Lives presenting SNO BABIES movie


Amy Winehouse Foundation logo

– SNO BABIES film available 29th September – available to watch via rental/purchase on Amazon, Apple TV, iTunes, Google Play and more

  • SNO BABIES soundtrack available 4th September on Better Noise Films

Today, Better Noise Music are proud to announce that the Amy Winehouse Foundation is now the official UK charity partner for the upcoming feature film from Better Noise Films, SNO BABIES. The Amy Winehouse Foundation supports young people affected by drug and alcohol problems, as well as providing drug and alcohol education in schools and recovery housing facilities for young women and is the perfect charity partner for Better Noise and SNO BABIES, whose main aim is to raise awareness of the opioid crisis globally.

The Amy Winehouse Foundation was set up by Amy’s family on 14 September 2011, on what would have been Amy’s 28th birthday. Since then, the charity has worked with over 300,000 children in schools; engaged with hundreds of people in recovery and continues to provide support, treatment and therapy for children and young people in the UK and overseas. Their programmes include:

  • The Amy Winehouse Foundation Resilience Programme – an evidence-based drug & alcohol awareness programme led by people in recovery and supporting children and students aged 11 upwards in schools, colleges and community settings.
  • Amy’s Place – an award-winning recovery housing project for women aged 18 to 30, which provides safe homes for up to two years in a nurturing environment where the young women can focus on their ongoing recovery from addiction.
  • Recovery Pathways Programme – working with professional partners to provide support, counselling, residential treatment and housing for young people aged 18-30.

Mitch Winehouse, Co-Founder of Amy Winehouse Foundation: “We know from personal experience the devastation and heartbreak that addiction can bring. Since setting up the Amy Winehouse Foundation in our daughter’s memory 9 years ago, we have learnt so much about this condition. We have also learnt that recovery is possible and people can go on to live wonderful and fulfilling lives. We’ve made it our mission to work with people in recovery and to support young people who are struggling with the same sorts of issues as Amy and we’re delighted that Better Noise and SNO BABIES are helping us to do that.”

Allen Kovac, CEO of Better Noise Music, says: “We are very proud to have partnered with the Amy Winehouse Foundation. They do such an incredible job in Amy’s name of educating people around what is becoming such a massive problem. Their work with young people is close to our heart and obviously reflects the harrowing storyline in the film. We look forward to saving lives together.”

This fits perfectly with Better Noise’s feature film SNO BABIES, which aims to raise awareness of the growing opioid crisis around the world. Set for global release on 29 September, SNO BABIES is a gripping and emotive tale that depicts the grim realities of teenage addiction and provides hope for recovery. Kristen and Hannah are best friends – smart, likeable and college-bound – and also addicted to heroin. The pair of seemingly unlikely addicts spiral down a path of destruction, hiding their secret from well-meaning but busy parents behind pink bedrooms and school uniforms. Directed by Bridget Smith and starring Katie Kelly (Game of Silence), Paola Andino (Queen of the South) and Michael Lombardi (Rescue Me), SNO BABIES shows how easy it can be to both miss and hide the signs of addiction. Outside of the UK, Better Noise Films’ share of profits is being donated to Global Recovery Initiatives (GRI).

In a mission to reduce the stigma of Substance Use Disorders (SUD) and make an impact, Better Noise Films has collaborated with Global Recovery Initiatives to use the film’s release as a platform to raise awareness of GRI’s efforts to provide access to recovery support services all around the world. The COVID-19 pandemic has increased the risk for those in recovery, for both catching the virus and more severe outcomes. Treatments and support systems are disrupted, and social isolation increases the risk for addiction, relapse and overdose deaths.

Additionally, the film’s soundtrack was released on 4 September and features some of today’s biggest rock artists, including Slash, Mötley Crüe and SIXX:A.M.’s Nikki Sixx, Def Leppard’s Joe Elliott, Slipknot’s Corey Taylor and more. All artist royalties from the soundtrack are being donated to The Global Recovery Initiative Foundation (GRI), with matching contributions by Better Noise Music.

September is Recovery Month, and the soundtrack and film will raise funds to support recovery for Global Recovery Initiatives, as well as the Amy Winehouse Foundation. With every stream or download of the soundtrack and film, you are contributing to helping someone in recovery and helping to save lives!

The trailer for SNO BABIES can be found at https://youtu.be/vNjnBn5KE8w

Link to the soundtrack on all platforms here: https://snobabies.ffm.to/soundtrack

Assets here: https://drive.google.com/drive/folders/1bZnC2ZFV2u0zsaOPo7Df-IF1Ds3TJWKu

#LetsSaveLives

EDITOR’S NOTES

Quotes from US reactions to the movie:

“This is more than a cautionary tale. It is a wake-up call. Parents need to take it to heart and not turn away. Teens need to wake up and pay attention.” – Debbie Lynn Elias, BEHIND THE LENS

“An important and powerful film that is sure to stick with you for days, if not weeks, after seeing it…Katie Kelly delivers an unforgettable tour-de-force performance.” – Scott Menzel, WE LIVE ENTERTAINMENT

“From the first minute I was hooked. Ridiculously powerful movie.” – RECOVERY TODAY

ABOUT BETTER NOISE MUSIC:

BETTER NOISE MUSIC is the premier independent music label under BETTER NOISE ENTERTAINMENT, a content creation and marketing company that produces music, books, films, documentaries, TV shows, theatrical productions and tours. Better Noise Music (formerly Eleven Seven Music), founded in 2006 by music industry veteran and independent pioneer Allen Kovac, focuses on artist development and has grown into a music industry independent powerhouse, with a roster including Five Finger Death Punch, AWOLNATION, Mötley Crüe, Atlas Genius, Papa Roach, Bad Wolves, Nothing More and The Hu. Partnering with FUGA, AMPED and Membran, the company operates a global marketing and distribution platform with offices in New York, Los Angeles, Nashville, London, Berlin, Toronto and Sydney. https://betternoise.com/

ABOUT BETTER NOISE FILMS

Better Noise Films (BNF), a Better Noise Entertainment company (BNE), is led by entertainment industry pioneer, Allen Kovac (CEO) and COO Dan Lieblein (Cinecom, October Films, and USA Films). BNF develops feature films, unique programming and other original content. Along with Better Noise Music, a leading global independent record label, Better Noise Films serves as an emerging platform for delivering top quality content that engages audiences, develops artists and builds the BNE brand. The company’s first 2 releases, SNO BABIES and THE RETALIATORS are due out autumn 2020.

ABOUT THE AMY WINEHOUSE FOUNDATION

Following Amy’s untimely death in 2011, the Winehouse family set up the Amy Winehouse Foundation to support, inform and inspire vulnerable and disadvantaged young people. Today, through their range of projects, they work with thousands of young people both in the UK and abroad. The charity has three core areas of focus:

  • To inform and educate young people about the effects of drug & alcohol misuse.
  • To provide support for those most vulnerable, those at high risk of misuse or disadvantaged through circumstance.
  • To support the personal development of disadvantaged children and young people through music


Registered charity no. 1143740 (England and Wales) http://www.amywinehousefoundation.org

Board Certified Internal Medicine Specialist, Dr. Deborah Ann Lozito Named NJ Top Doc


Dr. Deborah Ann Lozito

Dr. Deborah Ann Lozito

NJ Top Doc, Dr. Deborah Ann Lozito of Lozito Medical Associates has over 28 years of experience. She is committed to providing continuous, comprehensive, compassionate and personal care to each of her patients through every stage of life.

Dr. Lozito is board certified by the American Osteopathic Board of Internal Medicine. She received her education at The Philadelphia College of Osteopathic Medicine and completed her internship and residency at Union Hospital in New Jersey.

In 2008, she co-founded The Institute for Medical Weight Loss and Nutrition located in Hawthorne, New Jersey, to address the obesity epidemic. She works hard to successfully help her patients reach their goals.

Outside of Lozito Medical Associates, Dr. Lozito treats patients at and is affiliated with Valley Hospital in Ridgewood, New Jersey.

She is also a member of the American Osteopathic Association, American College of Osteopathic Physicians and the New Jersey Osteopathic Physician Association.

This NJ Top Doc is currently accepting new patients.

To learn more about Dr. Deborah Ann Lozito, please visit: https://njtopdocs.com/nj-doctors/drdeborahannlozito/

About Us

NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.

NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

For more information, please click here to contact us or visit http://www.NJTopDocs.com.

You can also follow us on Facebook, Twitter, & Instagram.

Share article on social media or email:



Little Steps Opens New Glenview Location, Launches Florida Company to Reach More Patients


Little Steps Pediatric Therapy logo.

It’s been tough for parents trying to help their kids with remote learning. We felt there was a need to bridge the gap with our enrichment pods.

Little Steps Pediatric Therapy has opened a second location in Glenview, Illinois and launched a new sister company in Florida to expand educational programs and reach new patients in need of therapeutic services. The new space in Glenview also allows for social distancing to prevent the spread of COVID-19.

After the pandemic prompted many schools to switch to virtual learning earlier this year, the Little Steps team decided to develop programming to help parents and supplement remote education. The pediatric therapy provider already offered a preschool readiness program to promote early learning and skills like social interaction, fine and gross motor skills, pre-writing, pre-language and more. As of this fall, Little Steps also assists children with skills like reading, handwriting and speech via enrichment pods for Pre-K through 5th-grade students.

The pods deliver supplemental instruction in core areas and are limited to eight participants each to allow for proper distancing. Each pod meets for 2.5 hours per session and is led by a team of Little Steps therapists. Please visit the enrichment pods section of the therapy provider’s website for more information.

The new Glenview site – located at 1850 Johns Dr. – allows Little Steps to deliver that socially distanced programming to assist children with e-learning, explained Jaime Passaglia, founder of Little Steps.    

“It’s been tough for parents trying to help their kids with remote learning,” Passaglia said. “We felt there was a need to bridge the gap with our enrichment pods. Our team has worked some of their e-learning instructions into the programming as well.”

Passaglia also launched a sister company, Little Steps Florida LLC, in Florida in August after team member Erica Vitaliano moved there. Vitaliano is a pediatric speech therapist and has served as the director of speech therapy services and Early Intervention therapy services for Little Steps. She now offers Early Intervention services and teletherapy in Florida. Passaglia plans to secure office space for the new company soon.

In addition to the two new locations, Little Steps already had sites in Chicago, Highland Park, Wilmette and Glenview to serve children throughout the Chicago metro area. The company focuses on delivering compassionate and comprehensive care – including pediatric physical, occupational and speech therapy – to children of all ages. For more information, please call 847-707-6744 or email info@littlestepspt.com.

About Little Steps

Little Steps Pediatric Therapy is a privately-owned company composed of pediatric professionals focused on delivering physical therapy, speech therapy, occupational therapy and behavior therapy to children of all ages in the Chicago area. Our team is determined to provide comprehensive and educational care to change the lives of children one step at a time. To learn more, visit littlestepspt.com.

For more information contact:

Kaley Rosinski

847-707-6744

info@littlestepspt.com

Share article on social media or email:

DuPont Human Microbiome Venture and Procter & Gamble Enter Research Collaboration in Next Generation Probiotics


News Image

“The combination of DuPont’s and P&G’s unique set of capabilities will allow us to accelerate innovation in the field of metabolic health and help millions of consumers affected by metabolic health issues,” said Sebastien Guery, Human Microbiome Venture leader, DuPont Nutrition & Biosciences.

The DuPont Human Microbiome Venture today announced a research partnership with The Procter & Gamble Company (P&G), focusing on the discovery and development of innovative next generation probiotics (NGPs) for human health.

Over the past years, both P&G and DuPont have conducted extensive research on human commensals to help address metabolic health issues in humans. In order to accelerate the development and commercialization of NGPs, both companies are joining forces to develop NGPs, initially to be used in dietary supplements.

There is an increasing number of studies that have shown that diet and poor lifestyle choices negatively affect the gut microbiota which can result in chronic low-grade inflammation which is closely associated with the onset and prevalence of metabolic health related conditions¹. On the contrary, increasing levels of certain anaerobic bacteria in the gut has been shown to increase insulin sensitivity and thus helps to maintain healthy blood sugar levels.²

“It’s an exciting opportunity to partner with P&G to jointly develop the next generation of microbe-based products. The combination of DuPont’s and P&G’s unique set of capabilities will allow us to accelerate innovation in the field of metabolic health and help millions of consumers affected by metabolic health issues,” said Sebastien Guery, Human Microbiome Venture leader, DuPont Nutrition & Biosciences.

“As a company focused on innovation, P&G is excited to come together with our valued partners at DuPont. Many consumers trust Align, the #1 doctor and gastroenterologist recommended probiotic brand³, to promote and support a healthy digestive system⁴. This strategic partnership will help us further advance our probiotic innovation via a next generation solution that will prove beneficial to the health and well-being of consumers around the world” said Paul Gama, president, P&G Personal Health Care.

¹Tilg H et al. The intestinal microbiota fuelling metabolic inflammation. Nature Reviews Immunology 2020; 20:40-54.

² Vrieze A et al. Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome. Gastroenterology 2012; 143:913–916.

³ Among Gastroenterologists who recommended a brand of probiotic in a ProVoice 2008-2019 survey. Among Doctors who recommended a brand of probiotic in ProVoice 2013-2019 surveys.

⁴ These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

About P&G

P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit http://www.pg.com for the latest news and information about P&G and its brands.

About DuPont Nutrition & Biosciences

DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. We are innovative solvers who help our customers turn challenges into high-value business opportunities. For more information: http://www.dupontnutritionandbiosciences.com

About DuPont

DuPont (NYSE: DD) is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, health and wellness, food, and worker safety. More information can be found at http://www.dupont.com/.

# # #

09/21/2020

DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.

Share article on social media or email:

Emanate Health’s Robert H. Curry Named Finalist for Hospital CEO of the Year by the Los Angeles Business Journal


Emanate Health President & CEO Robert H. Curry

Curry was one of five finalists for the award. Other finalists represented Adventist Health Glendale, UCLA Health, City of Hope and Keck Medicine of USC.

Emanate Health CEO Robert H. Curry, who oversees the largest the largest health care system in the San Gabriel Valley, has been named a finalist for “Hospital CEO or President of the Year” for the annual Health Care Panel and Awards.

“I feel privileged to be nominated with such an impressive group of Los Angeles County hospital leaders,” said Curry. “But this nomination says more about the outstanding doctors, nurses, staff members and volunteers who serve our patients every day than it does about me. Our staff is the backbone of our organization and they work hard to address the health care needs of our service area and bring wellness to our communities, especially during a global pandemic.”    

Curry, who has served in his current role since November 2008, was one of five finalists for the award. Other finalists included Alice Issai, President, Adventist Health Glendale; Johnese Spisso, President, UCLA Health, CEO, UCLA Hospital System, Associate Vice Chancellor, UCLA Health Sciences; Robert Stone, President and CEO, City of Hope and Rod Hanners, Interim CEO, Keck Medicine of USC

“Rob’s leadership has been invaluable in guiding Emanate Health during the pandemic to ensure our financial stability and preserve staff positions for our dedicated team of hospital heroes, who are bringing our communities back to good health in body, mind and spirit,” said Gary Mathewson, Chair, Emanate Health Board of Directors. “More importantly, Rob has implemented high standards of cleanliness and safety at our hospitals to protect our team of physicians, nurses and staff, and inspire confidence in our patients who are safely returning for treatment and no longer delaying their medical care.”

Curry was recognized by the Business Journal as one of the 500 most influential community and business leaders in Los Angeles County in 2020. He serves as the Board Chair for Private Essential Access Community Hospitals (PEACH) – a network of private, core safety net hospitals in California that care for a disproportionate share of low-income, medically vulnerable patients, among other industry and professional affiliations.

About Emanate Health

Emanate Health is the largest nonprofit health care provider serving the one million residents of the San Gabriel Valley in California. The system provides specialized care in Behavioral Health, Cancer, Cardiovascular, Emergency, Neuroscience and Stroke, Orthopedics, Sports Medicine, and Women’s Health. Its family of hospitals and hospice include Emanate Health Inter-Community in Covina, Emanate Health Queen of the Valley in West Covina, Emanate Health Foothill Presbyterian in Glendora, Emanate Health Hospice and Home Care in West Covina, as well as other clinics throughout the region. Year after year the health care system has been voted “Best Hospital” and “Best Place to Work” and providers are consistently among the “Top Doctors” in Los Angeles County and hospitals are graded A for Patient Safety by The Leapfrog Group. Visit emanatehealth.org, our Newsroom and connect with us on LinkedIn │Twitter │ Instagram │ Facebook.

Share article on social media or email:

San Francisco 13 year-old Creator of Safe Touch Pro, Launches “Operation Student Shield” Initiative to Help Students and Teachers get FREE Safety Devices during Pandemic


Michelle Klinger, a Minnesota teacher who teaches students with special needs and her school principal pictured in front of one of their donated boxes of Safe Touch Pros.

Michelle Klinger, a Minnesota educator, who teaches students with special needs and her school principal pictured in front of one of their donated boxes of Safe Touch Pros.

I basically reached out to him because his device saves lives. Make no mistake about it!

In the wake of COVID-19 spikes among U.S. students over the last few weeks amid school reopenings, 13 year-old, Mizan Rupan-Tompkins, creator of the Safe Touch Pro Handle, was inspired to launch an initiative to help every student and teacher, in hybrid and in-person learning environments, with FREE access to his germ-resistant devices during the pandemic. His antimicrobial plant-based safety device allows students and teachers to safely access classroom and school bathroom doors free of touch.

After being declared the 2020 “Better Days Ahead” winner by national safety advocacy organization, Safe and Sound Schools, Mizan received an email from a Minnesota teacher who teaches children with special needs. “She was asking about the cost of my product and she wanted to keep herself and her students safe. I told my parents I wanted her to have them without worrying about the price. So we sent them to her and her class for free,” he recounts. “I started reading news stories of COVID spikes in schools and hearing about concerned parents, teachers and students across the country and wanted to do something about it.”

Since schools have reopened in the U.S., COVID-19 spikes among students and teachers in certain areas of the country have caused many to question if current school safety guidelines are enough. Recently in Florida, coronavirus outbreaks and infections among school-age children jumped 34 percent.(1) Days ago, the Utah Education Association wrote its Board of Education, requesting better, “measures to protect the health and safety of public school students, educators and school staff,”. (2) And a number of California schools have reopened for in-person learning even while the state classifies most of its counties under “Widespread” COVID-19 status. (3)

“I basically reached out to him because his device saves lives. Make no mistake about it!” exclaims, San Mateo County, California, Board of Supervisors Vice President, David Canepa, who recently awarded Mizan a proclamation for his efforts to combat COVID-19.

Candice Celestina of Wisconsin, a supporter of “Operation Student Shield”, wrote, “Absolutely a great idea! :)”.

To learn more about “Operation Student Shield” and how to help, visit:

http://www.protecteverystudent.com or

http://www.safetouchprohandle.com/donate-to-schools

https://www.facebook.com/safetouchpro

About Safe Touch Pro

Safe Touch Pro was founded by 13 year-old, San Francisco-Bay Area resident, Mizan Rupan-Tompkins, who created the product and company after witnessing his parents struggle to open public doors with their sleeves, in the name of protecting themselves from Coronavirus. Safe Touch Pro is the first utility tool of its kind to use both antimicrobial silver ions to stop harmful microbes and be made of plant-based material.

At age 8, Mizan was tinkering with microprocessors and coding in several programming languages. By age 10 he had received accolades from Barnes & Noble bookstore as one of its “Mini Makers” of the year. Months later he found himself presenting his “Age Guessing Bot” at Maker Faire Bay Area to thousands of people.

Share article on social media or email: